Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc

Employees - 75, CEO - Patrick N. J. Schnegelsberg, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -15.51, Piotroski Score(max is 10): 4, Working Capital: $-35993000, Total Assets: $11703000, Retained Earnings: $-62126000, EBIT: -20742000, Total Liabilities: $45931000, Revenue: $4468000

AryaFin Target Price - $-2.6 - Current Price $ - Analyst Target Price $